OnyinyeCOnyekwereMDMS, FAAP

Pediatric Hematology & Oncology • Silver Spring, MD

Pediatric Anemia and Red Blood Cell Hematology

Pediatrics and Adolescent Medicine & Hematologist at Advanced Neighborhood Pediatrics, LLC. Clarksburg Maryland

Join to view full profile

Dr. Onyekwere is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Onyekwere's full profile

Already have an account?

Office
8607 2nd Ave Ste 505a
Silver Spring, MD 20910
Phone+1 240-641-8160

Fax+1 240-331-0073

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1999 - 2001
University of TennesseeFellowship, Pediatric Hematology/Oncology, 1998 - 1999
Sparrow HospitalResidency, Pediatrics, 1995 - 1998
Michigan State University College of Human MedicineClass of 1995

Certifications & Licensure

MD State Medical License 2005 - 2025
DC State Medical License 2002 - 2024
MI State Medical License 1997 - 2019
WV State Medical License 2015 - 2017
TN State Medical License 1998 - 1999
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

AOA Michigan State University CHM, 1996

Clinical Trials

A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients Start of enrollment: 2010 Jan 01
Completed

Publications & Presentations

PubMed

34 citations
Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia.
Manuel Arteta, Andrew D. Campbell, Mehdi Nouraie, Sohail Rana, Onyinye Onyekwere
Journal of Pediatric Hematology/oncology. 2014-04-01
23 citations
Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease
Rabindra N. Paul, Caterina P. Minniti, Mehdi Nouraie, Lori Luchtman-Jones, Andrew D. Campbell
European Journal of Haematology. 2013-07-01
73 citations
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.
Joshua J. Field, Gene Lin, Maureen Okam, Elaine M. Majerus, Jeffrey R. Keefer
Blood. 2013-04-25

Grant Support

Clinical Trial: ICL670National Center For Research Resources2009
AntheraNational Center For Research Resources2009
Inot36National Center For Research Resources2007–2009
Clinical Trial: Inot36National Center For Research Resources2008
Clinical Trial: HydroxyureaNational Center For Research Resources2008
ICL670National Center For Research Resources2006–2007
HydroxyureaNational Center For Research Resources2006–2007
Nitric OxideNational Center For Research Resources2006